|The CCNK ccnk (Catalog #MBS9222233) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The CCNK ccnk product has the following accession number(s) (GI #218511966) (NCBI Accession #O75909.2) (Uniprot Accession #O75909). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Regulatory subunit of cyclin-dependent kinases that mediates activation of target kinases. Plays a role in transcriptional regulation via its role in regulating the phosphorylation of the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A).
Cellular Location: Nucleus. Tissue Location: Ubiquitously expressed. Highest levels in testis. CCNK also interacts with the following gene(s): CDK12, CDK13, CDK2, CDK4, CDK6, CDK8, CDK9. Embryonic Tissue, Testis tissues are correlated with this protein. The following patways have been known to be associated with this gene. Adenocarcinoma, Ataxia, Breast Neoplasms, Carcinoma, Cardiovascular Diseases, Cell Transformation, Neoplastic, Hypertrophy, Neoplasms, Experimental are some of the diseases may be linked to CCNK Antibody (N-term) Blocking Peptide.